A New Strategy for Targeting UCP2 to Modulate Glycolytic Reprogramming as a Treatment for Sepsis A New Strategy for Targeting UCP2

Singe, M., C.S. Deutschman, C.W. Seymour, M. Shankar-Hari, D. Annane, M. Bauer, et al. 2016. The third international consensus definitions for sepsis and septic shock (Sepsis-3) [J]. Jama 315 (8): 801–10. https://doi.org/10.1001/jama.2016.0287.

Article  CAS  Google Scholar 

Rudd, K.E., S.C. Johnson, K.M. Agesa, K.A. Shackelford, D. Tsoi, D.R. Kievlan, et al. 2020. Global, regional, and national sepsis incidence and mortality, 1990–2017: analysis for the Global Burden of Disease Study [J]. Lancet (London, England) 395 (10219): 200–11. https://doi.org/10.1016/s0140-6736(19)32989-7.

Article  PubMed  Google Scholar 

Rudd, K.E., N. Kissoon, D. Limmathurotsakul, S. Bory, B. Mutahunga, C.W. Seymour, et al. 2018. The global burden of sepsis: barriers and potential solutions [J]. Critical care (London, England) 22 (1): 232. https://doi.org/10.1186/s13054-018-2157-z.

Article  PubMed  Google Scholar 

Stephen, A.H., R.L. Montoya, and A.R. Aluisio. 2020. Sepsis and septic shock in low- and middle-income countries [J]. Surgical infections 21 (7): 571–8. https://doi.org/10.1089/sur.2020.047.

Article  PubMed  Google Scholar 

Balk, R.A. 2000. Severe sepsis and septic shock. Definitions, epidemiology, and clinical manifestations [J]. Critical Care Clinics 16(2): 179–92. https://doi.org/10.1016/s0749-0704(05)70106-8.

Schortgen, F. 2012. Fever in sepsis [J]. Minerva anestesiologica 78 (11): 1254–1264.

CAS  PubMed  Google Scholar 

Vincent, J.L. 2022. Current sepsis therapeutics [J]. EBioMedicine 86.

Evans, T. 2018. Diagnosis and management of sepsis [J]. Clinical medicine (London, England) 18 (2): 146–9. https://doi.org/10.7861/clinmedicine.18-2-146.

Article  PubMed  Google Scholar 

Gauer, R., D. Forbes, and N. Boyer. 2020. Sepsis: Diagnosis and management [J]. American family physician 101 (7): 409–418.

PubMed  Google Scholar 

Mirijello, A., and  A. Tosoni. 2020. On Behalf of the Internal Medicine Sepsis Study G. New strategies for treatment of sepsis [J]. Medicina (Kaunas, Lithuania) 56(10). https://doi.org/10.3390/medicina56100527.

Vincent, J.L., G. Jones, S. David, E. Olariu, and K.K. Cadwell. 2019. Frequency and mortality of septic shock in Europe and North America: a systematic review and meta-analysis [J]. Critical care (London, England) 23 (1): 196. https://doi.org/10.1186/s13054-019-2478-6.

Article  PubMed  Google Scholar 

Evans, L., A. Rhodes, W. Alhazzani, M. Antonelli, C.M. Coopersmith, C. French, et al. 2021. Surviving sepsis campaign: international guidelines for management of sepsis and septic shock 2021 [J]. Critical care medicine 49 (11): e1063–e143. https://doi.org/10.1097/ccm.0000000000005337.

Article  PubMed  Google Scholar 

Wu, Y., Y.M. Yao, and Z.Q. Lu. 2019. Mitochondrial quality control mechanisms as potential therapeutic targets in sepsis-induced multiple organ failure [J]. Journal of molecular medicine (Berlin, Germany) 97 (4): 451–62. https://doi.org/10.1007/s00109-019-01756-2.

Article  CAS  PubMed  Google Scholar 

Font, M.D., B. Thyagarajan, and A.K. Khanna. 2020. Sepsis and septic shock - basics of diagnosis, pathophysiology and clinical decision making [J]. The Medical clinics of North America 104 (4): 573–85. https://doi.org/10.1016/j.mcna.2020.02.011.

Article  PubMed  Google Scholar 

Van Der Poll, T., M. Shankar-Hari, and W.J. Wiersinga. 2021. The immunology of sepsis [J]. Immunity 54 (11): 2450–64. https://doi.org/10.1016/j.immuni.2021.10.012.

Article  CAS  PubMed  Google Scholar 

Annesley, S.J., and  P.R. Fisher. 2019. Mitochondria in health and disease [J]. Cells 8(7). https://doi.org/10.3390/cells8070680

Cherry, A.D., and C.A. Piantadosi. 2015. Regulation of mitochondrial biogenesis and its intersection with inflammatory responses [J]. Antioxidants & redox signaling 22 (12): 965–76. https://doi.org/10.1089/ars.2014.6200.

Article  CAS  Google Scholar 

Zhang, H., Y.W. Feng, and Y.M. Yao. 2018. Potential therapy strategy: targeting mitochondrial dysfunction in sepsis [J]. Military Medical Research 5 (1): 41. https://doi.org/10.1186/s40779-018-0187-0.

Article  PubMed  PubMed Central  Google Scholar 

Zhang, C., Y. Zhao, M. Yu, J. Qin, B. Ye, and Q. Wang. 2022. Mitochondrial dysfunction and chronic liver disease [J]. Current issues in molecular biology 44 (7): 3156–65. https://doi.org/10.3390/cimb44070218.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Toda, C., and S. Diano. 2014. Mitochondrial UCP2 in the central regulation of metabolism [J]. Best practice & research Clinical endocrinology & metabolism 28 (5): 757–64. https://doi.org/10.1016/j.beem.2014.02.006.

Article  CAS  Google Scholar 

Hotchkiss, R.S., G. Monneret, and D. Payen. 2013. Sepsis-induced immunosuppression: from cellular dysfunctions to immunotherapy [J]. Nature reviews Immunology 13 (12): 862–74. https://doi.org/10.1038/nri3552.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Boomer, J.S., K. To, K.C. Chang, O. Takasu, D.F. Osborne, A.H. Walton, et al. 2011. Immunosuppression in patients who die of sepsis and multiple organ failure [J]. Jama 306 (23): 2594–605. https://doi.org/10.1001/jama.2011.1829.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, D., S.Y. Huang, J.H. Sun, H.C. Zhang, Q.L. Cai, C. Gao, et al. 2022. Sepsis-induced immunosuppression: mechanisms, diagnosis and current treatment options [J]. Military Medical Research 9 (1): 56. https://doi.org/10.1186/s40779-022-00422-y.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Palsson-Mcdermott,  E.M., and L.A. O’neill. 2013. The Warburg effect then and now: from cancer to inflammatory diseases [J]. BioEssays : news and reviews in molecular, cellular and developmental biology. 35(11): 965–73. https://doi.org/10.1002/bies.201300084.

Warburg, O., F. Wind, and E. Negelein. 1927. The metabolism of tumors in the body [J]. The Journal of general physiology 8 (6): 519–30. https://doi.org/10.1085/jgp.8.6.519.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Warburg, O. 1956. On the origin of cancer cells [J]. Science (New York, NY) 123 (3191): 309–14. https://doi.org/10.1126/science.123.3191.309.

Article  ADS  CAS  Google Scholar 

Benny, S., R. Mishra, M.K. Manojkumar, and T.P. Aneesh. 2020. From Warburg effect to Reverse Warburg effect; the new horizons of anti-cancer therapy [J]. Medical hypotheses 144.

Bar-Or, D., M. Carrick, A. Tanner 2nd., M.J. Lieser, L.T. Rael, and E. Brody. 2018. Overcoming the Warburg effect: is it the key to survival in sepsis? [J]. Journal of critical care 43: 197–201. https://doi.org/10.1016/j.jcrc.2017.09.012.

Article  PubMed  Google Scholar 

Samudio, I., M. Fiegl, and M. Andreeff. 2009. Mitochondrial uncoupling and the Warburg effect: molecular basis for the reprogramming of cancer cell metabolism [J]. Cancer research 69 (6): 2163–6. https://doi.org/10.1158/0008-5472.Can-08-3722.

Article  CAS  PubMed  Google Scholar 

Moon, J.S.,  S. Lee, M.A. Park, I. Siempos, M. Haslip, and P.J. Lee. et al. 2015. UCP2-induced fatty acid synthase promotes NLRP3 inflammasome activation during sepsis [J]. The Journal of clinical investigation 125(2): 665–80. https://doi.org/10.1172/jci78253.

Bouillaud, F. 2009. UCP2, not a physiologically relevant uncoupler but a glucose sparing switch impacting ROS production and glucose sensing [J]. Biochimica et biophysica acta 1787 (5): 377–83. https://doi.org/10.1016/j.bbabio.2009.01.003.

Article  CAS  PubMed  Google Scholar 

Hass, D.T., and C.J. Barnstable. 2021. Uncoupling proteins in the mitochondrial defense against oxidative stress [J]. Progress in retinal and eye research 83.

Esteves, P., C. Pecqueur, C. Ransy, C. Esnous, V. Lenoir, F. Bouillaud, et al. 2014. Mitochondrial retrograde signaling mediated by UCP2 inhibits cancer cell proliferation and tumorigenesis [J]. Cancer research 74 (14): 3971–82. https://doi.org/10.1158/0008-5472.Can-13-3383.

Article  CAS  PubMed  Google Scholar 

Ding, Y., Y. Zheng, J. Huang, W. Peng, X. Chen, X. Kang, et al. 2019. UCP2 ameliorates mitochondrial dysfunction, inflammation, and oxidative stress in lipopolysaccharide-induced acute kidney injury [J]. International immunopharmacology 71: 336–49. https://doi.org/10.1016/j.intimp.2019.03.043.

Article  CAS  PubMed  Google Scholar 

Rousset, S., Y. Emre, O. Join-Lambert, C. Hurtaud, D. Ricquier, and A.M. Cassard-Doulcier. 2006. The uncoupling protein 2 modulates the cytokine balance in innate immunity [J]. Cytokine 35 (3–4): 135–42. https://doi.org/10.1016/j.cyto.2006.07.012.

Article  CAS  PubMed  Google Scholar 

Tagen, M., A. Elorza, D. Kempuraj, W. Boucher, C.L. Kepley, and O.S. Shirihai. et al. 2009. Mitochondrial uncoupling protein 2 inhibits mast cell activation and reduces histamine content [J]. Journal of immunology (Baltimore, Md : 1950) 183(10): 6313–6319. https://doi.org/10.4049/jimmunol.0803422.

Emre, Y., and T. Nübel. 2010. Uncoupling protein UCP2: when mitochondrial activity meets immunity [J]. FEBS letters 584 (8): 1437–42. https://doi.org/10.1016/j.febslet.2010.03.014.

Article  CAS  PubMed  Google Scholar 

Liu, W., T. Liu, Y. Zheng, and Z. Xia. 2023. Metabolic reprogramming and its regulatory mechanism in sepsis-mediated inflammation [J]. Journal of inflammation research 16: 1195–207. https://doi.org/10.2147/jir.S403778.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cheng, S.C., L.A. Joosten, and M.G. Netea. 2014. The interplay between central metabolism and innate immune responses [J]. Cytokine & growth factor reviews 25 (6): 707–13. https://doi.org/10.1016/j.cytogfr.2014.06.008.

Article  CAS  Google Scholar 

Liu, J., G. Zhou, X. Wang, and D. Liu. 2022. Metabolic reprogramming consequences of sepsis: adaptations and contradictions [J]. Cellular and molecular life sciences : CMLS 79 (8): 456. https://doi.org/10.1007/s00018-022-04490-0.

Article  CAS  PubMed  Google Scholar 

Owen, A.M., S.P. Patel, J.D. Smith, B.K. Balasuriya, S.F. Mori, and G.S. Hawk. et al. 2019. Chronic muscle weakness and mitochondrial dysfunction in the absence of sustained atrophy in a preclinical sepsis model [J]. eLife 8. https://doi.org/10.7554/eLife.49920.

Peng, W., J. Huang, Y. Zheng, Y. Ding, S. Li, J. Zhang, et al. 2019. UCP2 silencing aggravates mitochondrial dysfunction in astrocytes under septic conditions [J]. Molecular medicine reports 20 (5): 4459–66.

留言 (0)

沒有登入
gif